Table 5.
Steroidal MRA | Non-Steroidal MRA | ||
---|---|---|---|
Characteristics | Spironolactone | Eplerenone | Finerenone |
Antagonism over MR | High | Low | High |
Antagonism over AR | High | Low | Low |
Effect on proteinuria and kidney damage | Moderate | Low | High |
BP reduction | High | Low | High |
Effect on HFpEF | Moderate | Moderate | High |
Effect on HFmrEF | Moderate | Moderate | High |
Effect on HFrEF | High | High | High |
Hyperkalemia | High | Moderate | Low |
Gynecomastia | High | Moderate | Low |
MRA = mineralocorticoid receptor antagonist; MR = mineralocorticoid receptor; AR = androgen receptor; BP = blood pressure; HFpEF = heart failure with preserved ejection fraction; HFmrEF = heart failure with moderately reduced ejection fraction; HFrEF = heart failure with reduced ejection fraction.